Market Research Logo

Ragweed Allergy - Pipeline Review, H2 2015

Ragweed Allergy - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Ragweed Allergy - Pipeline Review, H2 2015’, provides an overview of the Ragweed Allergy’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Ragweed Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ragweed Allergy and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Ragweed Allergy
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Ragweed Allergy and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Ragweed Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Ragweed Allergy pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Ragweed Allergy
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Ragweed Allergy pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Ragweed Allergy Overview
Therapeutics Development
Pipeline Products for Ragweed Allergy - Overview
Pipeline Products for Ragweed Allergy - Comparative Analysis
Ragweed Allergy - Therapeutics under Development by Companies
Ragweed Allergy - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Ragweed Allergy - Products under Development by Companies
Ragweed Allergy - Companies Involved in Therapeutics Development
Anergis SA
Biomay AG
Circassia Pharmaceuticals Plc
Immunomic Therapeutics, Inc.
Stallergenes S.A.
Ragweed Allergy - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Allergen for Ragweed Pollen Allergy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AllerR - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BM-34 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Multi-LAMP-Vax - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PL-101 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ragweed hypoallergenic vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Vaccine for Asthma, Ragweed Allergy and Rhino-Conjunctivitis - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ragweed Allergy - Recent Pipeline Updates
Ragweed Allergy - Dormant Projects
Ragweed Allergy - Discontinued Products
Ragweed Allergy - Product Development Milestones
Featured News & Press Releases
Dec 19, 2014: Anergis Granted U.S. Patent for Ragweed Allergy Vaccine AllerR
Dec 08, 2014: Circassia Announces Top-Line Results from Ragweed Allergy Treatment Phase IIb Chamber Study
Feb 21, 2013: Anergis To Present Preclinical Data On Ragweed Allergy Vaccine Candidate AllerR At AAAAI 2013 Annual Meeting
Jun 14, 2012: Anergis Reaches Several Preclinical Development Milestones With Ragweed Pollen Vaccine
Mar 07, 2012: Circassia’s Ragweed Allergy Therapy Achieves Positive Phase II Clinical Results
Jan 19, 2012: Circassia Receives European Patent For Its Ragweed Allergy T-Cell Vaccine
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Ragweed Allergy, H2 2015
Number of Products under Development for Ragweed Allergy - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Ragweed Allergy - Pipeline by Anergis SA, H2 2015
Ragweed Allergy - Pipeline by Biomay AG, H2 2015
Ragweed Allergy - Pipeline by Circassia Pharmaceuticals Plc, H2 2015
Ragweed Allergy - Pipeline by Immunomic Therapeutics, Inc., H2 2015
Ragweed Allergy - Pipeline by Stallergenes S.A., H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Ragweed Allergy Therapeutics - Recent Pipeline Updates, H2 2015
Ragweed Allergy - Dormant Projects, H2 2015
Ragweed Allergy - Discontinued Products, H2 2015
List of Figures
Number of Products under Development for Ragweed Allergy, H2 2015
Number of Products under Development for Ragweed Allergy - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Top 10 Molecule Types, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report